Adult GlioblastomaPhase 1NCT04573140Papers
Autologous total tumor mRNA
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
A 20-mer peptide spanning the IDH1 R132H substitution, designed to raise a CD4+ T-cell response against a mutation the tumour cannot easily lose.
Mechanism explainer
Film in production
The drug
Most WHO grade 2 and 3 gliomas carry the same amino-acid change in isocitrate dehydrogenase 1: arginine 132 becomes histidine. That single substitution is both a diagnostic marker and a shared neoantigen — a mutant peptide the immune system can, in principle, see.
The vaccine is not a whole-cell product and not a personalized construct. It is one synthetic 20-mer peptide that spans the R132H mutation, given with an immune adjuvant. The aim is to present that peptide on MHC class II and recruit mutation-specific helper T cells.
Because R132H is an early, truncal event, every tumour cell is expected to keep it. That is the scientific bet: a target the glioma cannot shed without becoming a different disease.
The study
NOA-16 was a first-in-human study of the IDH1 R132H peptide vaccine in patients with IDH1-mutant gliomas. It asked whether the construct was safe, whether it induced mutation-specific T cells, and whether those cells could be found in blood and in tumour.
The published readout is immunological rather than a survival claim. Patients mounted IDH1-specific immune responses, and the work sits behind later, larger vaccine efforts in the same mutation.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.